HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's consumer label study to test "information processing benefits" of revised format.

This article was originally published in The Rose Sheet

Executive Summary

FDA OTC LABEL STUDY TESTING "INFORMATION PROCESSING BENEFITS" OF REVISED FORMAT will provide the agency "with in-formation about the conditions under which revised format benefits may be realized," FDA states in a May 12 outline of two consumer studies the agency intends to perform to evaluate its newly proposed standardized OTC label format. The label comprehension study, which will involve 1,200 subjects, will manipulate the conditions under which the participants are reading the OTC labels to determine whether format variations, when read "under more realistic...conditions when attentional resources are limited," help the consumer process the information in the label.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel